Search for: "Merck, Sharpe "
Results 201 - 220
of 262
Sort by Relevance
|
Sort by Date
24 Feb 2012, 2:08 pm
Merck Sharp & Dohme Corp. [read post]
23 Feb 2012, 11:45 am
Merck Sharp & Dohme Corp., ATL-L-9169-11, ALT-L-9166-11; ATL-L-9142-11; ATL-L-9168-11; ATL-L-9157-011, at 3 (N.J. [read post]
16 Feb 2012, 1:33 pm
According to the Merck Manual, peripheral neuropathy is “dysfunction of one or more peripheral nerves. [read post]
29 Dec 2011, 11:02 am
Three More Lawsuits (Boles, Jellema, and Spano) Set For Trial, And A Special Master Appointed To Conduct Settlement Talks (Posted by Tom Lamb at DrugInjuryWatch.com) There are currently more than 900 Fosamax lawsuits pending against defendant Merck Sharp & Dohme Corp. [read post]
13 Dec 2011, 5:49 am
MERCK in Merck Sharp & Dohme Corp. v. [read post]
4 Dec 2011, 1:42 pm
With the consent of the Plaintiffs’ Steering Committee and defendant Merck Sharp & Dohme Corp., the Court hereby appoints John D. [read post]
29 Nov 2011, 11:24 am
Merck Sharp & Dohme, one of the country’s largest pharmaceutical companies, has agreed to pay $950 million to settle both civil fraud allegations and criminal charges relating to the promotion of the painkiller Vioxx. [read post]
28 Nov 2011, 6:31 am
The Department of Justice recently announced a resolution with pharmaceutical giant Merck, Sharp & Dohme ("Merck") to pay $950 million to settle criminal and civil claims for its illegal promotion and marketing of its painkiller drug, Vioxx. [read post]
27 Nov 2011, 10:33 am
American pharmaceutical company Merck, Sharp & Dohme (Merck) will pay $950 million to resolve criminal charges and civil claims related to its promotion and marketing of the painkiller Vioxx® (rofecoxib). [read post]
23 Nov 2011, 7:35 pm
Pharmaceutical Company Merck Sharp & Dohme to Pay Nearly One Billion Dollars Over Promotion of Vioxx" [read post]
23 Nov 2011, 8:32 am
Pharmaceutical Company Merck Sharp & Dohme to... [read post]
22 Nov 2011, 4:57 am
According to DOJ’s press release: American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal charges and civil claims related to its promotion and marketing of the painkiller Vioxx® (rofecoxib), the Justice Department announced today. [read post]
17 Nov 2011, 5:20 am
Prescription drug maker Merck Sharp & Dohme Corp. filed an action against Kentucky Attorney General Jack Conway challenging the legality and fairness of the arrangement in which a state attorney general hires private attorneys on a contingency fee basis to handle suits on behalf of the state. [read post]
3 Aug 2011, 3:31 am
General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
28 Jul 2011, 3:33 pm
207/10, Orifarm v Merck Sharpe & Dohme; Paranova v Merck Sharp & Dohme, sped through in pretty good time. [read post]
5 Jul 2011, 5:39 am
HPV vaccines, such as Gardasil, which are manufactured by Merck Sharp & Dohme Co., have been aggressively marketed to young girls in their early teens as well as their parents. [read post]
5 Jul 2011, 5:39 am
HPV vaccines, such as Gardasil, which are manufactured by Merck Sharp & Dohme Co., have been aggressively marketed to young girls in their early teens as well as their parents. [read post]
26 May 2011, 7:09 am
See Merck & Co., Inc. v. [read post]
25 May 2011, 11:46 pm
Therasense, now Abbott, got into a patent battle involving 5,820,551 and similar patents claiming "disposable blood glucose test strips for diabetes management. [read post]
18 May 2011, 12:33 am
Merck (EPLAW) Byetta, Bydureon (Exenatide) – US: Amylin files suit against Eli Lilly alleging anticompetitive activity and breach of strategic alliance agreements (GenericsWeb) Copegus (Ribavarin) – Portugal: Lisbon Court of Appeal accepts registration for CORIÉGUS for dietetic substance – CORIÉGUS v. [read post]
